http://www.thepharmaletter.comThe Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the Pharmaceuticals, Biotechnology and Generics sectors of the overall health care industry, backed by a team of respected writers with many years of experience in the field.Register for free for our daily email...Tue, 20 Apr 2010 12:48:33 +0100News from the webhttp://www.thepharmaletter.com/file/96378/analgesics-dominican-republic-market-report-new-market-report-published.htmlThe Dominican Government has supported generics as a way to make medicines more affordable to the country's low-income population. The gains of allowing the ...http://www.thepharmaletter.com/file/96378/analgesics-dominican-republic-market-report-new-market-report-published.htmlMon, 05 Jul 2010 10:33:17 +0100http://www.thepharmaletter.com/file/96386/parent-co-ups-stake-in-jianmin-pharmaceutical.htmlJuly 5 -- Holley Group, the parent company of Wuhan Jianmin Pharmaceutical Group (600976) increased its holdings in Jianmian by 3.62 million shares or a ...http://www.thepharmaletter.com/file/96386/parent-co-ups-stake-in-jianmin-pharmaceutical.htmlMon, 05 Jul 2010 08:14:23 +0100http://www.thepharmaletter.com/file/96384/serbias-pharmaceutical-sector-is-being-hampered-by-difficult-conditions.htmlSerbia's pharmaceutical sector is being hampered by difficult economic and political conditions but will grow year-on-year (yoy) from 2010. ...http://www.thepharmaletter.com/file/96384/serbias-pharmaceutical-sector-is-being-hampered-by-difficult-conditions.htmlMon, 05 Jul 2010 08:02:09 +0100http://www.thepharmaletter.com/file/96370/expert-urges-govt-to-step-up-formation-of-nt60-b-biotech-fund.htmlLee, also chairman of the Development Center for Biotechnology and former chairman of Industrial Technology Research Institute, remarked that Taiwan should ...http://www.thepharmaletter.com/file/96370/expert-urges-govt-to-step-up-formation-of-nt60-b-biotech-fund.htmlMon, 05 Jul 2010 07:27:29 +0100http://www.thepharmaletter.com/file/96381/drug-testing-platform-will-benefit-pharmaceutical-sector.htmlScientists in England are developing a new drug testing platform that promises to bring long-term benefits to the pharmaceutical industry. ...http://www.thepharmaletter.com/file/96381/drug-testing-platform-will-benefit-pharmaceutical-sector.htmlMon, 05 Jul 2010 06:33:48 +0100http://www.thepharmaletter.com/file/96373/new-market-study-published-israel-pharmaceuticals-healthcare-report-q3-2010.htmlWhile the Israeli government has established a US$250mn biotechnology fund to rejuvenate the innovative drug development sector, the local drugmaking sector ...http://www.thepharmaletter.com/file/96373/new-market-study-published-israel-pharmaceuticals-healthcare-report-q3-2010.htmlMon, 05 Jul 2010 01:55:42 +0100http://www.thepharmaletter.com/file/96382/japan-stocksrohto-pharmaceutical-co.htmlJAPAN STOCKS:Rohto Pharmaceutical Co. (4527) plans to invest Y2 billion on increasing production of cosmetics and medicines in Asia outside of Japan, ...http://www.thepharmaletter.com/file/96382/japan-stocksrohto-pharmaceutical-co.htmlMon, 05 Jul 2010 01:32:21 +0100http://www.thepharmaletter.com/file/96377/prasco-to-market-authorized-generic-of-zegerid.htmlPrasco Laboratories announced today that it is now shipping the authorized generic version of ZEGERID (omeprazolesodium bicarbonate) capsules. ...http://www.thepharmaletter.com/file/96377/prasco-to-market-authorized-generic-of-zegerid.htmlSun, 04 Jul 2010 21:11:46 +0100http://www.thepharmaletter.com/file/96371/scientists-create-hiv-fighting-immune-cells-in-lab-mice.html... than the cost of years of battling the disease, HealthDay News reports. The study has been published in the June 2, 2010 edition of Nature Biotechnology.http://www.thepharmaletter.com/file/96371/scientists-create-hiv-fighting-immune-cells-in-lab-mice.htmlSun, 04 Jul 2010 19:39:06 +0100http://www.thepharmaletter.com/file/96387/govt-resolves-to-facilitate-all-pharmaceutical-companies.htmlKARACHI: Federal Minister for Environment Hameed Ullah Jan Afridi said some multinational pharmaceutical industries are catering the needs for about 25 ...http://www.thepharmaletter.com/file/96387/govt-resolves-to-facilitate-all-pharmaceutical-companies.htmlSun, 04 Jul 2010 01:34:17 +0100http://www.thepharmaletter.com/file/96368/call-to-embracecommercialise-biotechnology.htmlBy Beldina Nyakeke Tanzanians have been urged to embrace and commercialise biotechnology and allow the genetically modified organisms (GMO) in order to give ...http://www.thepharmaletter.com/file/96368/call-to-embracecommercialise-biotechnology.htmlSat, 03 Jul 2010 06:17:48 +0100http://www.thepharmaletter.com/file/96379/battle-over-biosimilar-drugs-is-only-for-the-brave.htmlAnnual treatment costs for patented biologics running into the tens of thousands of dollars per patient have attracted generics makers such as Novartis ...http://www.thepharmaletter.com/file/96379/battle-over-biosimilar-drugs-is-only-for-the-brave.htmlFri, 02 Jul 2010 15:01:41 +0100http://www.thepharmaletter.com/file/96331/medivation-is-among-the-companies-in-the-biotechnology-industry-with-the-best-.htmlBelow are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on ...http://www.thepharmaletter.com/file/96331/medivation-is-among-the-companies-in-the-biotechnology-industry-with-the-best-.htmlFri, 02 Jul 2010 10:27:16 +0100http://www.thepharmaletter.com/file/96341/pharma-a-second-wave-of-generics-opportunity.htmlGeneric companies thrive when a large number of drugs lose patents. This largely holds true in the US generics market. After all, it is the biggest pharma ...http://www.thepharmaletter.com/file/96341/pharma-a-second-wave-of-generics-opportunity.htmlFri, 02 Jul 2010 09:36:24 +0100http://www.thepharmaletter.com/file/96349/pharmaceutical-firms-are-going-to-the-dogs.htmlNow, Madison Avenue advertisers for pharmaceutical companies are looking for more markets. They're convincing dog owners there's more to dog health than ...http://www.thepharmaletter.com/file/96349/pharmaceutical-firms-are-going-to-the-dogs.htmlFri, 02 Jul 2010 09:33:07 +0100http://www.thepharmaletter.com/file/96332/synta-pharmaceuticals-leads-the-companies-in-the-biotechnology-industry-.htmlBelow are the top five companies in the Biotechnology industry as measured by the price to sales per share ratio. Often companies with the ...http://www.thepharmaletter.com/file/96332/synta-pharmaceuticals-leads-the-companies-in-the-biotechnology-industry-.htmlFri, 02 Jul 2010 09:29:26 +0100http://www.thepharmaletter.com/file/96340/glenmark-pharma-makes-a-mark-after-us-nod-for-a-generic-drug.htmlThe drug is a generic equivalent of Galderma's Differin gel which generated approximately $84 million in sales for the 12 month period ending March 2010, ...http://www.thepharmaletter.com/file/96340/glenmark-pharma-makes-a-mark-after-us-nod-for-a-generic-drug.htmlFri, 02 Jul 2010 08:26:51 +0100http://www.thepharmaletter.com/file/96346/swine-flu-uk-praised-but-told-to-beware-big-pharma.htmlInterestingly, both reviews were critical of the role of big pharmaceutical companies during the swine flu pandemic. The UK review, revealed yesterday by ...http://www.thepharmaletter.com/file/96346/swine-flu-uk-praised-but-told-to-beware-big-pharma.htmlFri, 02 Jul 2010 07:44:02 +0100http://www.thepharmaletter.com/file/96327/bilski-v-kappos-what-effects-on-biotechnology-patents.htmlKappos: What Effects on Biotechnology Patents? By Kevin E. Noonan -- Although long-anticipated, the Supreme Court's opinion in Bilski v. ...http://www.thepharmaletter.com/file/96327/bilski-v-kappos-what-effects-on-biotechnology-patents.htmlFri, 02 Jul 2010 06:24:12 +0100http://www.thepharmaletter.com/file/96348/furiex-pharmaceuticals-announces-issuance-of-us-patent-for-dapoxetine-method-.htmlFuriex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of ...http://www.thepharmaletter.com/file/96348/furiex-pharmaceuticals-announces-issuance-of-us-patent-for-dapoxetine-method-.htmlThu, 01 Jul 2010 21:57:13 +0100http://www.thepharmaletter.com/file/96338/prasco-to-market-zegerid-generic.htmlPrasco Laboratories said Thursday that it is marketing the authorized generic version of Zegerid, an ulcer and esophageal reflux disease treatment. ...http://www.thepharmaletter.com/file/96338/prasco-to-market-zegerid-generic.htmlThu, 01 Jul 2010 18:30:25 +0100http://www.thepharmaletter.com/file/96350/jiangbo-pharmaceuticals-names-linxian-jin-ceo.htmlChinese drugmaker Jiangbo Pharmaceuticals Inc. said Thursday Linxian Jin has been appointed CEO, replacing Wubo Cao, who resigned Tuesday. ...http://www.thepharmaletter.com/file/96350/jiangbo-pharmaceuticals-names-linxian-jin-ceo.htmlThu, 01 Jul 2010 18:27:27 +0100http://www.thepharmaletter.com/file/96333/biotechnology-stocks-participating-in-broad-market-sell-off.html(RTTNews) - After showing a steep move to the downside at the open, biotechnology stocks continue to see notable weakness in late morning trading on ...http://www.thepharmaletter.com/file/96333/biotechnology-stocks-participating-in-broad-market-sell-off.htmlThu, 01 Jul 2010 16:45:38 +0100http://www.thepharmaletter.com/file/96337/sun-pharma-announces-launch-of-generic-exelonr-in-us.htmlThese generic rivastigmine capsules are therapeutically equivalent of Novartis Exelon(R) Capsules and include four strengths: 1.5 mg (base), 3 mg (base), ...http://www.thepharmaletter.com/file/96337/sun-pharma-announces-launch-of-generic-exelonr-in-us.htmlThu, 01 Jul 2010 16:16:26 +0100http://www.thepharmaletter.com/file/96344/teva-launches-generic-effexor-xr.html1) Teva Pharmaceutical Industries has launched the first generic version of a drug used for treating depression and anxiety. ...http://www.thepharmaletter.com/file/96344/teva-launches-generic-effexor-xr.htmlThu, 01 Jul 2010 16:10:18 +0100http://www.thepharmaletter.com/file/96345/columbia-laboratories-stockholders-approve-sale-of-progesterone-assets-to-.htmlColumbia Laboratories, Inc. is a specialty pharmaceutical company focused on developing products for the women's healthcare and endocrinology markets that ...http://www.thepharmaletter.com/file/96345/columbia-laboratories-stockholders-approve-sale-of-progesterone-assets-to-.htmlThu, 01 Jul 2010 16:06:24 +0100http://www.thepharmaletter.com/file/96334/drug-stocks-slump-arena-jumps-in-early-action.htmlThe NYSE Arca Pharmaceutical Index (NYSE:DRG) was down marginally at 275.74 and the NYSE Arca Biotechnology Index (NYSE:BTK) fell 1.8% to 1004.30. ...http://www.thepharmaletter.com/file/96334/drug-stocks-slump-arena-jumps-in-early-action.htmlThu, 01 Jul 2010 14:51:44 +0100http://www.thepharmaletter.com/file/96328/innexus-biotechnology-amends-collaborative-agreement-with-the-national-cancer-.htmlCHANDLER, Ariz., Jul 01, 2010 (BUSINESS WIRE) -- InNexus Biotechnology Inc. (TSX: IXS.V) (www.ixsbio.com), a leading drug development company ...http://www.thepharmaletter.com/file/96328/innexus-biotechnology-amends-collaborative-agreement-with-the-national-cancer-.htmlThu, 01 Jul 2010 14:06:35 +0100http://www.thepharmaletter.com/file/96307/cabinet-council-analyses-national-pharmaceutical-policy.htmlThe national pharmaceutical policy aims at guaranteeing supply of secure, efficient and quality medicine, as well securing the permanent availability of ...http://www.thepharmaletter.com/file/96307/cabinet-council-analyses-national-pharmaceutical-policy.htmlThu, 01 Jul 2010 10:43:02 +0100http://www.thepharmaletter.com/file/96290/neurocrine-biosciences-is-among-the-companies-in-the-biotechnology-industry-.htmlBelow are the top five companies in the Biotechnology industry as measured by relative performance. This analysis was compiled based on ...http://www.thepharmaletter.com/file/96290/neurocrine-biosciences-is-among-the-companies-in-the-biotechnology-industry-.htmlThu, 01 Jul 2010 10:19:17 +0100http://www.thepharmaletter.com/file/96296/astrazeneca-antitrust-fine-cut-by-13-by-eu-court.htmlIn a report last July the EU said companies use a variety of techniques to delay generics. Today's is the first case in which the commission, the antitrust ...http://www.thepharmaletter.com/file/96296/astrazeneca-antitrust-fine-cut-by-13-by-eu-court.htmlThu, 01 Jul 2010 09:39:35 +0100http://www.thepharmaletter.com/file/96289/oxigene-has-the-highest-upside-potential-in-the-biotechnology-industry-oxgn-.htmlBelow are the top five companies in the Biotechnology industry as measured by the potential gains between the current stock price and the ...http://www.thepharmaletter.com/file/96289/oxigene-has-the-highest-upside-potential-in-the-biotechnology-industry-oxgn-.htmlThu, 01 Jul 2010 09:17:30 +0100http://www.thepharmaletter.com/file/96288/biotech-onwards-and-upwards.htmlThe UK's Eastern Region Biotechnology Initiative (Erbi), the not-for-profit membership company for international life science and healthcare businesses, ...http://www.thepharmaletter.com/file/96288/biotech-onwards-and-upwards.htmlThu, 01 Jul 2010 08:50:28 +0100http://www.thepharmaletter.com/file/96281/biogen-chooses-scientist-as-chief.htmlBiogen Idec Inc. named George A. Scangos, a West Coast biotechnology executive and University of Massachusetts-trained ...http://www.thepharmaletter.com/file/96281/biogen-chooses-scientist-as-chief.htmlThu, 01 Jul 2010 04:25:44 +0100http://www.thepharmaletter.com/file/96299/reckitt-to-focus-acquisitions-on-health-personal-care-units.htmlReckitt expects sales at its pharmaceutical division to slump by as much as 80 percent in the US when generics flood the market for Suboxone, which lost its ...http://www.thepharmaletter.com/file/96299/reckitt-to-focus-acquisitions-on-health-personal-care-units.htmlThu, 01 Jul 2010 00:45:51 +0100http://www.thepharmaletter.com/file/96287/dendreon-shares-pummeled-as-medicare-studies-coverage.htmlShares of Seattle biotechnology company Dendreon were slammed in after-hours trading Wednesday after Medicare regulators said they were opening an inquiry ...http://www.thepharmaletter.com/file/96287/dendreon-shares-pummeled-as-medicare-studies-coverage.htmlThu, 01 Jul 2010 00:36:31 +0100http://www.thepharmaletter.com/file/96294/pharmerica-achieves-75-generic-dispensing-rate.htmlThe generic dispensing rate is on track to exceed 80% by 2013. Accelerating the generic dispensing rate are over 15 major drugs going off patent by 2013, ...http://www.thepharmaletter.com/file/96294/pharmerica-achieves-75-generic-dispensing-rate.htmlWed, 30 Jun 2010 22:26:38 +0100http://www.thepharmaletter.com/file/96293/santarus-to-slash-work-force-as-competitor-releases-generic.htmls (PRX) generic version. Santarus shares were up 1.5%, at $2.52 in after-hours trading. The stock has fallen 12% in the last year, worse than the broader ...http://www.thepharmaletter.com/file/96293/santarus-to-slash-work-force-as-competitor-releases-generic.htmlWed, 30 Jun 2010 21:47:59 +0100http://www.thepharmaletter.com/file/96303/theres-a-lot-to-like-about-teva.htmlTeva Pharmaceutical is a large Israel-based global pharmaceutical company that develops, manufactures, and markets generic and proprietary drugs. ...http://www.thepharmaletter.com/file/96303/theres-a-lot-to-like-about-teva.htmlWed, 30 Jun 2010 19:34:05 +0100http://www.thepharmaletter.com/file/96306/china-nuokang-bio-pharmaceutical-announces-agreement-to-market-dianatalr-.htmlDianatal(R) Obstetric Gel is currently marketed in Switzerland, Germany, UK and Central Europe with leading pharmaceutical companies, such as GSK and Sandoz ...http://www.thepharmaletter.com/file/96306/china-nuokang-bio-pharmaceutical-announces-agreement-to-market-dianatalr-.htmlWed, 30 Jun 2010 17:01:50 +0100http://www.thepharmaletter.com/file/96302/biosante-pharmaceuticals-announces-positive-clinical-results-in-pill-plustm-.htmlThe Pill-Plus United States patents for oral use are licensed by BioSante to Pantarhei Bioscience, a Netherlands-based pharmaceutical company, ...http://www.thepharmaletter.com/file/96302/biosante-pharmaceuticals-announces-positive-clinical-results-in-pill-plustm-.htmlWed, 30 Jun 2010 13:01:59 +0100http://www.thepharmaletter.com/file/96308/raptor-pharmaceutical-announces-license-agreement-for-conviviatm.htmlCurrently, 4-MP is the active pharmaceutical ingredient in an existing intravenous therapeutic approved by the US Food and Drug Administration ("FDA") for ...http://www.thepharmaletter.com/file/96308/raptor-pharmaceutical-announces-license-agreement-for-conviviatm.htmlWed, 30 Jun 2010 11:37:03 +0100http://www.thepharmaletter.com/file/96260/alembic-to-demerge-pharma-business.htmlIndia's oldest pharmaceutical company Alembic went one step closer to the biggest restructuring in its history as its board ...http://www.thepharmaletter.com/file/96260/alembic-to-demerge-pharma-business.htmlWed, 30 Jun 2010 08:59:21 +0100http://www.thepharmaletter.com/file/96263/pharmaceutical-firm-to-build-plant-at-kaec.htmlEmaar the Economic City (EEC) has signed an agreement with pharmaceutical company Sanofi-aventis, for the company to build a manufacturing facility at the ...http://www.thepharmaletter.com/file/96263/pharmaceutical-firm-to-build-plant-at-kaec.htmlWed, 30 Jun 2010 08:05:55 +0100http://www.thepharmaletter.com/file/96256/octoplus-announces-agreement-with-a-major-pharmaceutical-company-on-its-.htmlOctoPlus is a drug delivery company committed to the creation of improved pharmaceutical products that are based on OctoPlus' proprietary drug delivery ...http://www.thepharmaletter.com/file/96256/octoplus-announces-agreement-with-a-major-pharmaceutical-company-on-its-.htmlWed, 30 Jun 2010 06:42:28 +0100http://www.thepharmaletter.com/file/96250/generic-drug-battle-moves-to-quebec.html29, 2010 5:40PM EDT Get ready for the battle over generic drugs, part deux. Generic pharmaceutical manufacturers and drugstore chains operating in Quebec ...http://www.thepharmaletter.com/file/96250/generic-drug-battle-moves-to-quebec.htmlTue, 29 Jun 2010 22:42:02 +0100http://www.thepharmaletter.com/file/96255/alembic-hives-off-pharma-biz-into-new-firm-to-unlock-value.htmlAlembic Pharma will comprise generics, domestic formulations and international active pharmaceutical ingredients (API) business. On the other hand, ...http://www.thepharmaletter.com/file/96255/alembic-hives-off-pharma-biz-into-new-firm-to-unlock-value.htmlTue, 29 Jun 2010 20:31:29 +0100http://www.thepharmaletter.com/file/96264/amag-pharmaceuticals-and-takeda-announce-acceptance-of-submission-of-feraheme-.htmlLocated in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan ...http://www.thepharmaletter.com/file/96264/amag-pharmaceuticals-and-takeda-announce-acceptance-of-submission-of-feraheme-.htmlTue, 29 Jun 2010 11:36:37 +0100http://www.thepharmaletter.com/file/96215/app-pharmaceuticals-to-market-anastrozole-tablets-in-the-us.htmlAPP Pharmaceuticals and Fresenius Kabi Oncology Limited are members of the Fresenius Kabi Group of companies. Anastrozole is therapeutically equivalent to ...http://www.thepharmaletter.com/file/96215/app-pharmaceuticals-to-market-anastrozole-tablets-in-the-us.htmlTue, 29 Jun 2010 06:07:01 +0100